Advertisement
Advertisement
U.S. Markets open in 8 hrs 6 mins
Advertisement
Advertisement
Advertisement
Advertisement

Xtant Medical Holdings, Inc. (XTNT)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.5702-0.0648 (-10.20%)
At close: 03:46PM EST
0.5700 -0.00 (-0.04%)
After hours: 07:41PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6350
Open0.6000
Bid0.0000 x 1200
Ask0.0000 x 1000
Day's Range0.5601 - 0.6056
52 Week Range0.5300 - 6.5800
Volume25,555
Avg. Volume105,718
Market Cap49.491M
Beta (5Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateFeb 22, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Xtant Medical to Present at the H.C. Wainwright BioConnect Virtual Conference

    BELGRADE, Mont., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022. A pre-recorded presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com, beginning on

  • GlobeNewswire

    Xtant Medical Appoints Scott Neils Interim Chief Financial Officer

    BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Interim Chief Financial Officer succeeding Greg Jensen, the Company’s current Vice President, Finance and Chief Financial Officer, effective January 3, 2022. “We are excited to announce this well deserved promotion for Scott. His demonstrated

  • GlobeNewswire

    Xtant Medical Announces Third Quarter 2021 Financial Results

    BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, 2021. Third Quarter 2021 Financial Highlights: Revenue for the third quarter of 2021 totaled $13.8 million, compared to $14.0 million for the prior-year periodLoss from operations totaled $1.4 million co

Advertisement
Advertisement